Briana Contreras

1 week ago | managedhealthcareexecutive.com | Briana Contreras

Artificial intelligence (AI) is playing a significant role in how cancer is treated, both in terms of clinical outcomes and patient experience. At City of Hope, a cancer treatment and research center, Simon Nazarian, the system executive vice president and chief digital and technology officer, and Nasim Eftekhari, the executive director of applied AI and data science, are at the forefront of integrating AI into cancer care.

2 weeks ago | managedhealthcareexecutive.com | Briana Contreras |Peter Wehrwein

In this second part of a video series, editors of Managed Healthcare Executive spoke with Shawn Kwatra, M.D., professor and chair of dermatology at the University of Maryland School of Medicine, about challenges in treating chronic itch and how managed care policies may be limiting patient access to innovative therapies. Kwatra shared that chronic itch, often overlooked, can severely impact quality of life.

2 weeks ago | managedhealthcareexecutive.com | Briana Contreras

More than $7 million in grants are being awarded to organizations in Georgia, Michigan, New Mexico and Wisconsin to improve maternal and infant healthcare, reduce disparities and strengthen the doula workforce in underserved communities through efforts by the United Health Foundation, the charitable branch of UnitedHealth Group.

2 weeks ago | managedhealthcareexecutive.com | Peter Wehrwein |Briana Contreras

Shawn Kwatra, M.D., professor and chair of dermatology at the University of Maryland School of Medicine, shared with Managed Healthcare Executive that while chronic pruritus, or long-lasting itch, has a history of challenging patients and physicians, recent years have brought significant progress in how this condition is understood and treated. The first major breakthrough, Kwatra shared, is the development of new therapies that can directly target what causes chronic itch.

2 weeks ago | managedhealthcareexecutive.com | Pearl Steinzor |Briana Contreras

The 340B Drug Pricing Program, originally created to provide affordable medications for low-income patients, is finding itself in the hot seat due to its increased expansion and rising costs to employers and state governments. At the 2025 AMCP annual meeting in Houston from March 31 to April 3, John M. O'Brien, Pharm.D., MPH, president and CEO of the National Pharmaceutical Council (NPC), shared concerns and potential reforms in a conversation with Managed Healthcare Executive.